A structurally minimized yet fully active insulin based on cone-snail venom insulin principles
AuthorXiong, X; Menting, JG; Disotuar, MM; Smith, NA; Delaine, CA; Ghabash, G; Agrawal, R; Wang, X; He, X; Fisher, SJ; ...
Source TitleNature Structural and Molecular Biology
PublisherNATURE PUBLISHING GROUP
University of Melbourne Author/sLawrence, Michael
AffiliationMedical Biology (W.E.H.I.)
Document TypeJournal Article
CitationsXiong, X., Menting, J. G., Disotuar, M. M., Smith, N. A., Delaine, C. A., Ghabash, G., Agrawal, R., Wang, X., He, X., Fisher, S. J., MacRaild, C. A., Norton, R. S., Gajewiak, J., Forbes, B. E., Smith, B. J., Safavi-Hemami, H., Olivera, B., Lawrence, M. C. & Chou, D. H. -C. (2020). A structurally minimized yet fully active insulin based on cone-snail venom insulin principles. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 27 (7), pp.615-+. https://doi.org/10.1038/s41594-020-0430-8.
Access StatusAccess this item via the Open Access location
Open Access URLhttps://europepmc.org/articles/PMC7374640?pdf=render
Human insulin and its current therapeutic analogs all show propensity, albeit varyingly, to self-associate into dimers and hexamers, which delays their onset of action and makes blood glucose management difficult for people with diabetes. Recently, we described a monomeric, insulin-like peptide in cone-snail venom with moderate human insulin-like bioactivity. Here, with insights from structural biology studies, we report the development of mini-Ins-a human des-octapeptide insulin analog-as a structurally minimal, full-potency insulin. Mini-Ins is monomeric and, despite the lack of the canonical B-chain C-terminal octapeptide, has similar receptor binding affinity to human insulin. Four mutations compensate for the lack of contacts normally made by the octapeptide. Mini-Ins also has similar in vitro insulin signaling and in vivo bioactivities to human insulin. The full bioactivity of mini-Ins demonstrates the dispensability of the PheB24-PheB25-TyrB26 aromatic triplet and opens a new direction for therapeutic insulin development.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References